Trends in Molecular Medicine

Papers
(The median citation count of Trends in Molecular Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Advisory Board and Contents269
Subscription and Copyright Information263
Subscription and Copyright Information228
Advisory Board and Contents228
Advisory Board and Contents170
Subscription and Copyright Information141
Subscription and Copyright Information141
Fc-optimized checkpoint antibodies for cancer immunotherapy140
Consideration of the importance of measuring thermal discomfort in biomedical research137
Cellular senescence in neuroinflammatory disease: new therapies for old cells?123
Lymph node microenvironment rewires ferroptosis redox defenses116
Opportunities and challenges for biomarker discovery using electronic health record data109
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes102
Beneath the radar: immune-evasive cell sources for stroke therapy102
Neutrophils and extracellular traps in crystal-associated diseases102
m6A and beyond: RNA modifications shaping angiogenesis96
Microbiota: a dawn for cancer metastasis therapy96
The right drug at the right time: key to IBD success93
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease92
d-Amino acids: new clinical pathways for brain diseases88
Bursts of brain erosion: seizures and age-dependent neurological vulnerability86
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers82
Pushing the boundaries of brain organoids to study Alzheimer’s disease82
Advisory Board and Contents82
Brain-specific regulatory T cell expansion limits cognitive decline81
Erythropoietic protoporphyrias: updates and advances79
Amyloid and collagen templates in aortic valve calcification73
Is endometriosis a progressive disease?73
Hormesis as an adaptive response to infection71
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models66
Insights from HIV-1 vaccine and passive immunization efficacy trials66
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality64
Engineering cytokines for tumor-targeting and selective T cell activation61
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments60
Molecular mechanisms in the pathogenesis of dengue infections59
Epigenetic regulation in intervertebral disc degeneration58
Three ‘E’ challenges for siRNA drug development58
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients57
Microbes and mood: innovative biomarker approaches in depression57
Acquired resistance to immunotherapy in solid tumors57
Emerging roles of cyclin-dependent kinase 7 in health and diseases56
Keratinocytes: new perspectives in inflammatory skin diseases56
Mitigating age-related somatic mutation burden55
Promoting proteostasis by cAMP/PKA and cGMP/PKG54
Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation54
Tick-borne encephalitis: emerging clinical trends and challenges53
SOX17: escape route from immune destruction in early CRC52
Subscription and Copyright Information52
Subscription and Copyright Information51
Shining a light on comorbidities51
Roadmap for developing biologically inspired therapeutics for genetic brain disorders50
Subscription and Copyright Information46
Leptin and male fertility: unraveling the molecular pathways, receptor functions, and therapeutic potential46
Significant challenges to translating breakthrough science in Mexico46
The endoplasmic reticulum proteostasis network and bone disease45
Overcoming rabies immune evasion via monoclonal antibody therapeutics45
Antibody signatures in inflammatory bowel disease: current developments and future applications44
Strategies and challenges for non-viral delivery of non-coding RNAs to the heart44
Pathogenic mechanisms in genetically defined Ehlers–Danlos syndromes44
Subscription and Copyright Information41
Science around the world41
The bleeding edge: broadening horizons for hematopoietic stem cell therapies40
From pixels to patients: the evolution and future of deep learning in cancer diagnostics40
Saving eyesight, one gene at a time40
Time-restricted feeding and Alzheimer’s disease: you are when you eat39
Decoding atopic dermatitis: pathophysiology, clinical diagnosis, and treatments39
Translation of gene therapy strategies for amyotrophic lateral sclerosis38
Naked mole-rats: at the heart of it38
Timing matters: maternal milk IgG sets weaning threshold38
Two-pronged immune evasion of pseudouridine-modified RNA38
Focused ultrasound gene delivery for the treatment of neurological disorders37
Molecular disease mechanisms of human antineuronal monoclonal autoantibodies36
The emerging Janus face of SVEP1 in development and disease35
Targeting mitochondrial transfer as a promising therapeutic strategy34
Maternal obesity: new placental paradigms unfolded34
IL-15 in CAR engineering: striking an efficacy–safety balance34
CaMKK2: A tumor stress-integration node34
Advisory Board and Contents33
Science around the world33
Leveraging zebrafish to investigate pancreatic development, regeneration, and diabetes32
Unraveling host genetics and microbiome genome crosstalk: a novel therapeutic approach31
Advisory Board and Contents31
Translational opportunities emerge from genetic influences on health31
Cystic fibrosis at a glance: from disease mechanism to therapy30
Subscription and Copyright Information30
Crucial nuances in understanding (mis)associations between the neonatal microbiome and Cesarean delivery30
Advisory Board and Contents30
Molecular basis and clinical implications of TANGO2 deficiency disorder29
The overlooked uterine factor: unlocking endometrium potential in premature ovarian insufficiency29
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health29
HIF2 drives PTHrP-mediated cancer cachexia29
Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer29
Incorporating placental pathology into clinical care and research28
ABC transporters: human disease and pharmacotherapeutic potential28
The global human gut microbiome: genes, lifestyles, and diet28
Endosomal signaling disorders: a new category for immune dysregulation28
Autoantibodies as drivers of neuropathic pain27
Gasdermins in pyroptosis, inflammation, and cancer27
Fibroblasts in AKI: small army, big help27
Lipedema: a chronic adipose tissue disease27
Biodiversity: the overlooked source of human health27
Advisory Board and Contents26
iPSC-derived models for anorexia nervosa research26
Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes26
Subscription and Copyright Information26
From pixels to patients: the evolution and future of deep learning in cancer diagnostics26
Subscription and Copyright Information26
BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia26
Advisory Board and Contents26
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease25
Novel universal vaccines to mitigate emerging avian influenza viruses25
Molecular basis and clinical implications of HIFs in cardiovascular diseases25
Human dopaminergic system in the exercise-cognition link25
TIM-3 blockade: immune and targeted therapy in DIPG24
Vaccine-based immunotherapy and related preclinical models for glioma24
Advisory Board and Contents24
Subscription and Copyright Information24
Autoimmune diseases and cardiovascular risk23
Keratin 16 puts the brakes on type I interferon signalling23
Asthma exacerbations: the Achilles heel of asthma care23
Vitiligo: advances in pathophysiology research and treatment development23
Renin–angiotensin system: a novel target for brain health23
Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction22
Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma22
Epigenetic remodeling after viral pneumonia accelerates lung tumorigenesis22
Foxp3+ Tregs in HCC immunity and immunotherapy22
mRNA vaccine platforms to prevent bacterial infections22
Advisory Board and Contents21
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma21
Organ-specific aging in the plasma proteome predicts disease21
Staging of Alzheimer’s disease: past, present, and future perspectives21
Thirty years of molecular medicine: reflections from an academic physician-scientist, 1995–202521
HPV integration and cervical cancer: a failed evolutionary viral trait21
There is nothing as inconsistent as the OSFED diagnostic criteria20
Amyotrophic lateral sclerosis: A rare but aggressive adult-onset disease20
Missing links in preeclampsia cell model systems of endothelial dysfunction20
Bioelectronic medicine potentiates endogenous NSCs for neurodegenerative diseases20
Redefining metalloproteases specificity through network proteolysis20
Treating Niemann-Pick C lysosomal storage: approved and emerging approaches20
Why we must fight ignorance about COVID-19 vaccines and menstrual cycles20
Repurposing of microbial proteins as new-generation therapeutic agents for biomedical applications20
Telomere biology disorders: time for moving towards the clinic?20
Primary cilia shape hallmarks of health and aging19
Engaging the ZBP1 axis: from nucleic acid stress to antitumor immunity19
Copy number alterations: a catastrophic orchestration of the breast cancer genome19
Common mechanisms in pediatric acute liver failure19
The future of phage therapy in the USA19
The dual role of the TSC complex in cancer19
Predicting healthspan and disease risks through biological age19
Tertiary lymphoid structures in the central nervous system19
Advisory Board and Contents18
Dysfunctional tRNA reprogramming and codon-biased translation in cancer18
Treatment and research needs for severe eating disorders: a response to Dr Ayton18
Rejuvenating the human gut microbiome18
Precision medicine targeting ferroptosis in cerebrovascular diseases18
Dynamic rewiring of neurovasculature in health and disease17
Safety of non-replicative and oncolytic replication-selective HSV vectors17
Clinical crusade: zosurabalpin's charge against antibiotic resistance17
The aging lipidome: exercise is medicine17
Advisory Board and Contents17
Adenoviruses in medicine: innocuous pathogen, predator, or partner17
Multiomics tools for improved atherosclerotic cardiovascular disease management17
Nanocarrier vaccines for respiratory infections17
IL-6: a pivotal molecule for tumor–brain dysfunction interaction17
Cancer driver mutations: predictions and reality17
Advisory Board and Contents17
Short-chain fatty acids in fetal development and metabolism16
Digital health applications for eating disorders treatment16
Advisory Board and Contents16
Brain-related sexual dimorphism in tuberous sclerosis complex: an overlooked matter16
Nontraditional models as research tools: the road not taken16
Bearing allostatic load: insights into a more equitable future within cardio-oncology16
Are GLP-1R agonists the long-sought-after panacea for obesity?16
Subscription and Copyright Information16
Advances in Hodgkin lymphoma research16
Targeting the hyaluronic acid–CD44 axis in hepatocellular carcinoma16
Targeting endoplasmic reticulum stress and nitroso–redox imbalance in cancer progression16
Targeting the NAD+–PARP1–XRCC1 axis in ALS15
Block, expose, and immunize: triple attack on cancer15
Advisory Board and Contents15
Interdisciplinary approaches for the discovery of novel antifungals15
Science around the world15
Epigenetic regulation of tumor-immune symbiosis in glioma15
Subscription and Copyright Information15
Exploring new frontiers in type 1 diabetes through advanced mass-spectrometry-based molecular measurements14
Pig models for translational Duchenne muscular dystrophy research14
Nanobodies as a powerful platform for biomedicine14
Understanding preeclampsia: from phenotypes to treatment14
Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer14
Subscription and Copyright Information14
Updates and advances in pyruvate kinase deficiency13
Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases13
Targeting pathological ERK1/2 signaling in cancer and beyond13
Clonal hematopoiesis of indeterminate potential: the root cause of, and fertile ground for, hematological malignancies13
Gene therapy for β-thalassemia: current and future options13
Advisory Board and Contents12
Subscription and Copyright Information12
Patients as biomedical researchers12
Subscription and Copyright Information12
Subscription and Copyright Information12
ILC2s in cancer: good, bad, or stay tuned?12
Advisory Board and Contents12
Correction to: siRNA modification and delivery for drug development12
Metabolic symphony coordinates the muscle regeneration niche12
Advisory Board and Contents11
Physical activity, cathepsin B, and cognitive health11
Development of asparagine endopeptidase inhibitors for treating neurodegenerative diseases11
Antibody class-switching as a strategy to improve HIV-1 neutralization11
Erythroid–hormonal axis in long COVID11
From pathophysiology to treatment in transthyretin cardiac amyloidosis11
Subscription and Copyright Information11
Barrier organ mechanomedicine and therapeutic insights11
Can’t handle the stress? Mechanobiology and disease11
Cholesterol efflux in HIV-associated atherosclerosis: mechanisms and targets11
Patient-specific liver assembloids for disease modeling10
SARS-CoV-2 targets the liver and manipulates glucose metabolism10
The body is not just impacted by eating disorders – biology drives them10
Genetic causes of obesity: mapping a path forward10
Pulmonary fibrosis: from pathogenesis to clinical decision-making10
Subscription and Copyright Information10
Psoriatic arthritis: diagnosis, pathogenesis, and emerging therapies10
Science around the world10
Cell-free and extrachromosomal DNA profiling of small cell lung cancer10
Advancements and challenges in mouse models of Alzheimer’s disease10
Recent insights into lysosomal acid lipase deficiency10
Advisory Board and Contents10
Post-acute anti-NMDAR encephalitis mirrors schizophrenia10
Erythrophagocytes in hemolytic anemia, wound healing, and cancer10
Exploiting pancreatic cancer metabolism: challenges and opportunities10
Next-generation immune profiling – beyond blood cancer cells10
Narcolepsy type 1: an autoimmune disease9
Imaging genomics: data fusion in uncovering disease heritability9
Powering immunity: mitochondrial dynamics in natural killer cells9
Polycystic kidney disease: novel insights into polycystin function9
Molecular therapy for polyQ disorders: from bench to clinical trials9
A sex-biased target against demyelination in Alzheimer’s disease9
Pulmonary arterial hypertension and cancer: exploring their resemblance as channelopathies9
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation9
RyR-mediated calcium release in hippocampal health and disease9
Burden of hereditary enamel disorders9
Patient-specific trophoblast stem cells for placental medicine9
Technologies for chimeric antigen receptor transgene delivery9
Subscription and Copyright Information8
Tryptophan metabolites at the service of neuroimmune sensing of microbes8
Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications8
Subscription and Copyright Information8
Neurotransmitter-activated GPCR signaling in myelin plasticity8
Subscription and Copyright Information8
Host–microbe interactions in NAD+ metabolism8
Science around the world8
0.10698890686035